Cargando…
Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994337/ https://www.ncbi.nlm.nih.gov/pubmed/35395813 http://dx.doi.org/10.1186/s13071-022-05256-0 |
| _version_ | 1784684087265460224 |
|---|---|
| author | Rohdich, Nadja Meyer, Leon Guerino, Frank |
| author_facet | Rohdich, Nadja Meyer, Leon Guerino, Frank |
| author_sort | Rohdich, Nadja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8994337 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89943372022-04-10 Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis Rohdich, Nadja Meyer, Leon Guerino, Frank Parasit Vectors Correction BioMed Central 2022-04-08 /pmc/articles/PMC8994337/ /pubmed/35395813 http://dx.doi.org/10.1186/s13071-022-05256-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Rohdich, Nadja Meyer, Leon Guerino, Frank Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis |
| title | Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis |
| title_full | Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis |
| title_fullStr | Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis |
| title_full_unstemmed | Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis |
| title_short | Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis |
| title_sort | correction to: fluralaner 5.46% (w/w) favored chewable tablet (bravecto® 1-month) is effective for treatment of canine generalized demodicosis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994337/ https://www.ncbi.nlm.nih.gov/pubmed/35395813 http://dx.doi.org/10.1186/s13071-022-05256-0 |
| work_keys_str_mv | AT rohdichnadja correctiontofluralaner546wwfavoredchewabletabletbravecto1monthiseffectivefortreatmentofcaninegeneralizeddemodicosis AT meyerleon correctiontofluralaner546wwfavoredchewabletabletbravecto1monthiseffectivefortreatmentofcaninegeneralizeddemodicosis AT guerinofrank correctiontofluralaner546wwfavoredchewabletabletbravecto1monthiseffectivefortreatmentofcaninegeneralizeddemodicosis |